Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease

Fig. 2

The baseline and follow-up FDG-PET scans showed changes in SUVmax1/SUVliver during treatment. a Serial FDG-PET scans of 17 patients. The red lines represent patients who experienced disease progression during treatment. The blue lines represent patients who died during treatment. The gray lines represent patients who experienced continuous clinical improvement. b Serial FDG-PET scans of one patient who experienced continuous clinical improvement. The most active target lesion of the patient at baseline was right ilium (arrow). Compared with baseline, SUV max1/SUVliver increased at 3 months and 12 months after treatment. Without changing treatment strategy, SUV max1/SUVliver decreased at 18 months and 24 months after treatment

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172